Vitrolife AB (publ) (STO:VITR)
Sweden · Delayed Price · Currency is SEK 93.75
-1.00 (-1.06%)
Sep 24, 2026, 5:29 PM CET
Vitrolife AB Market Cap
Vitrolife AB has a market cap or net worth of 12.7 billion as of September 24, 2026. Its market cap has decreased by -27.44% in one year.
Market Cap
12.70B
Enterprise Value
13.48B
Revenue
3.39B
Ranking
n/a
PE Ratio
n/a
Stock Price
93.75
ChartMarket Cap Chart
Since June 27, 2001, Vitrolife AB's market cap has increased from 510.85M to 12.70B, an increase of 2,385.24%. That is a compound annual growth rate of 13.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 12.70B | -31.57% |
| Dec 30, 2025 | 18.55B | -36.27% |
| Dec 30, 2024 | 29.11B | 10.43% |
| Dec 29, 2023 | 26.36B | 4.56% |
| Dec 30, 2022 | 25.21B | -66.75% |
| Dec 30, 2021 | 75.82B | 223.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Getinge AB | 65.59B |
| Sectra AB | 54.06B |
| Elekta AB | 20.43B |
| Nolato AB | 14.52B |
| MedCap AB | 7.99B |
| Xvivo Perfusion AB | 7.56B |
| CellaVision AB | 3.98B |
| BICO Group AB | 1.58B |